Robert Cunningham - 23 Sep 2022 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Director
Signature
/s/ Robert Cunningham
Issuer symbol
AXIM
Transactions as of
23 Sep 2022
Net transactions value
$0
Form type
4
Filing time
23 Sep 2022, 16:29:31 UTC
Previous filing
23 Sep 2022
Next filing
19 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Award $0 +1,000,000 +200% $0.000000 1,500,000 23 Sep 2022 Common Stock 1,000,000 $0.0520 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date.